Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-19.34%
↓ 628% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-2.65%
Historical baseline
PeriodValueYoY Change
2025-19.34%+62.4%
2024-51.46%+25.4%
2023-68.99%-114.3%
2022-32.19%-288.1%
2021-8.29%+48.7%
2020-16.15%-120.8%
201977.77%-20.2%
201897.42%-